ID
26883
Beskrivning
Study ID: 101468/199 Clinical Study ID: 101468/199 Study Title: An open label study conducted in healthy volunteers to characterize the pharmacokinetics of a new unmarketed formulation of ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome Documentation part (Visit Description): Non-Serious Adverse Event
Nyckelord
Versioner (1)
- 2017-10-27 2017-10-27 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
27 oktober 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Pharmacokinetics of a new unmarketed formulation of ropinirole Non-Serious Adverse Event 101468/199
Similar models
Non-Serious Adverse Event
- StudyEvent: ODM
C0244821 (UMLS CUI-2)
C0011900 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C2697889 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0806020 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C1518404 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C0443172 (UMLS CUI-2)
(Comment:en)
C0178602 (UMLS CUI-2)
(Comment:en)
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])